United States · FDA National Drug Code directory
LEVETIRACETAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 36000-265_3312be87-d596-4fbe-91f6-9bacf7ac8869
- Product NDC
- 36000-265
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- levetiracetam
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260806
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-DOSE in 1 CARTON (36000-265-05) / 5 mL in 1 VIAL, SINGLE-DOSE (36000-265-01) · 36000-265-05
- 10 VIAL, SINGLE-DOSE in 1 CARTON (36000-265-10) / 5 mL in 1 VIAL, SINGLE-DOSE (36000-265-01) · 36000-265-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →